Teriparatide
Also known as: Forteo, PTH 1-34
Key Facts: Teriparatide
- Category
- Hormonal
- FDA Status
- FDA Approved
- Clinical Status
- FDA Approved - Osteoporosis
- Administration
- Subcutaneous injection daily
- Typical Dose
- 20 mcg daily
- Frequency
- Once daily
- Evidence Level
- FDA Approved
- Duration
- Maximum 2 years (lifetime limit due to osteosarcoma concern)
What to Expect
A recombinant fragment of parathyroid hormone that stimulates bone formation. FDA approved for osteoporosis with high fracture risk.
Mechanism of Action
Teriparatide contains amino acids 1-34 of PTH. Intermittent dosing stimulates osteoblasts more than osteoclasts, resulting in net bone formation. This anabolic effect differs from antiresorptive osteoporosis drugs.
Research Summary
Fracture Prevention Trial showed 65% reduction in vertebral fractures. Only bone-building (anabolic) therapy available until abaloparatide. Increases bone mineral density more effectively than bisphosphonates initially.
Dosing Information
Typical Dosingⓘ
Community experience
20 mcg daily
20 mcg daily
Once daily
FDA-approved PTH analog for osteoporosis. Max 2 years treatment. Injection in thigh or abdomen.
Research Dosingⓘ
Scientific studies
FDA-approved dosing
Doses from Studies
20 mcg subcutaneous daily
Duration
Maximum 2 years (lifetime limit due to osteosarcoma concern)
Administration
Subcutaneous injection daily
Timing & Administration
Best Time to Take
Morning or as directed
Follow recommended protocol
Food Recommendation
With or without food
Why This Timing?
Timing may vary based on individual response and goals. Consistency is generally more important than specific timing.
Possible Side Effects
Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.
- ●Joint pain (10%)
- ●Nausea
- ●Headache
- ●Dizziness
- ●Leg cramps
- ●Injection site reactions
- ●Orthostatic hypotension
- ●Hypercalcemia
- ●BOXED WARNING: Osteosarcoma risk - limit to 2 years
- ●FDA approved (Forteo)
References
Related Peptides
Peptides commonly compared with Teriparatide or used in similar applications.
Oxytocin
FDAA naturally occurring peptide hormone crucial for social bonding, childbirth, and lactation. Being studied for autism, anxiety, and social disorders.
HormonalGonadorelin
FDAA synthetic version of gonadotropin-releasing hormone. Used diagnostically and therapeutically for various reproductive and hormonal conditions.
HormonalLeuprolide
FDAA GnRH agonist that suppresses testosterone and estrogen production. FDA approved for prostate cancer, endometriosis, uterine fibroids, and precocious puberty.
HormonalDesmopressin
FDAA synthetic analog of vasopressin (ADH) used for diabetes insipidus, bedwetting, and bleeding disorders. Does not cause vasoconstriction like natural vasopressin.
HormonalOctreotide
FDAA synthetic somatostatin analog that inhibits multiple hormones. Used for acromegaly, carcinoid tumors, and various GI conditions.
HormonalLanreotide
FDAA long-acting somatostatin analog similar to octreotide. FDA approved for acromegaly and gastroenteropancreatic neuroendocrine tumors.
HormonalWant updates on Teriparatide research?
Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.
Educational Information Only
This information is provided for educational purposes only and is not intended as medical advice. Always consult with qualified healthcare providers before making any decisions about peptides or other substances. The protocols listed reflect doses observed in research studies, not recommendations.